MetaNovas Biotech

MetaNovas Biotech is a leading force in the biotechnology and pharmaceutical industries, leveraging advanced AI and biotechnology to revolutionize health and beauty. The company has established strategic partnerships with renowned global brands such as L'Oréal, Beiersdorf, Haleon, Takeda, and Unilever, showcasing its influence and credibility in the market. With a recent $10.00M Seed Round investment from Sinopharm Capital, NeuX Capital, and Redhill Capital on 31 March 2022, MetaNovas Biotech has demonstrated its appeal to notable investors. This investment reflects confidence in the company's potential and the innovative approach they apply to product development. MetaNovas Biotech's commitment to merging scientific discovery with practical application underscores its mission to introduce transformative and sustainable solutions to the market. The company's focus on uncovering pioneering active ingredients and formulating products that not only deliver visible results but also contribute to overall well-being positions it as a key player in the future of personal care and nutrition. As a U.S.-based company founded in 2021, MetaNovas Biotech is dedicated to shaping the future of the industry by creating a legacy of innovation and excellence. The company's impressive blend of cutting-edge science and AI technology holds promise for delivering groundbreaking health and beauty products.